We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pozen appoints Dr Tomas Bocanegra head of development

News

Executive Summary

Pozen has appointed Dr Tomas Bocanegra executive vice-president of development, responsible for driving all product development activities beginning with the company's lead pipeline candidate, PA32540 (aspirin and omeprazole), for myocardial infarction. Prior to joining Pozen, Dr Bocanegra served as senior vice-president of development at Daiichi Sankyo Pharma Development.